These tumours included cylindromas and spiradenomas from patients with germline mutations in CYLD. Tissue sections were probed with anti‐MYB antibody and protein expression was visualized using immunohistochemistry (Figure 2A, B). This evidence concerns the gene MYB and benign spiradenoma.